7 Tirzepatide is a unimolecular, bifunctional peptide invented by Eli Lilly and Company (Indianapolis, IN, USA), which simultaneously activates GLP-1R and GIPR
Prevalence and trends of the diabetes epidemic in urban and rural India: a pooled systematic review and meta-analysis of 17 million adults
Dose escalation continues through 4mg and 8mg phases before reaching the maintenance dose of 12mg
Patients considering these treatments should discuss their individual risk profile with their prescribing clinician, particularly if they have a history of pancreatic disease
It is the result of a poor oral-health routine
Additionally, phosphatidylserine may also positively impact age-related cognitive decline, combat depression, and aid ADHD symptoms